Frango Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -27.27%
(FY 2023)
- Profit -28.17%
(FY 2023)
- Ebitda -44.31%
(FY 2023)
- Net Worth 4.67%
(FY 2023)
- Total Assets -4.80%
(FY 2023)
About Frango Life Science
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramasamy Kuppusamy, Mayilvaganam Sivagamisundari, Kousalya Batula, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999KA2016PTC094203
- Company No.
094203
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Frango Life Science?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramasamy Kuppusamy  | Director | 17-Jun-2016 | Current |
| Mayilvaganam Sivagamisundari | Director | 17-Jun-2016 | Current |
| Kousalya Batula | Director | 17-Jun-2016 | Current |
| Mamatha Bhaskarachar | Director | 17-Jun-2016 | Current |
| Balakrishnan Vijayalakshmi | Director | 16-Dec-2020 | Current |
Financial Performance of Frango Life Science.
Frango Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.27% decrease. The company also saw a substantial fall in profitability, with a 28.17% decrease in profit. The company's net worth moved up by a moderate rise of 4.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Frango Life Science?
In 2023, Frango Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chandira Choodeswarar Educational FoundationActive 11 years 11 monthsRamasamy Kuppusamy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Frango Life Science?
Frango Life Science has a workforce of 4 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Frango Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Frango Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
